Literature DB >> 1732719

Phase II metabolism of warfarin in primary culture of adult rat hepatocytes.

R L Jansing1, E S Chao, L S Kaminsky.   

Abstract

We used adult rat hepatocytes in primary culture (HPC) as a model system to study the hepatic phase II metabolism of the anticoagulant warfarin. Hepatocytes were isolated by a collagenase perfusion technique and maintained for 24 hr in Waymouth's medium containing 0.1 mM (R)-warfarin. When HPC medium was analyzed by reverse phase high performance liquid chromatography with diode-array detection, 4'-, 6-, and 7-hydroxywarfarin were identified. Several putative conjugates were observed eluting between 13 and 18 min. Treatment of hepatocyte medium with beta-glucuronidase and sulfatase resulted in the loss of five putative conjugates and concomitant increases in 4'-, 6-, and 7-hydroxywarfarin and warfarin, suggesting that these metabolites and warfarin were conjugated. Use of the beta-glucuronidase inhibitor saccharic acid 1,4-lactone enabled the determination of the relative extents of conjugation of each metabolite by glucuronic acid and sulfate. Glucuronidation was the predominant pathway for 4'-hydroxywarfarin, whereas 6-hydroxywarfarin and warfarin occurred mainly as sulfate conjugates. In contrast, 7-hydroxywarfarin was converted to both glucuronide and sulfate conjugates. Exposure of HPC to phenobarbital resulted in a decrease in cytochrome P-450-mediated production of hydroxylated warfarin metabolites; however, an increase in the production of 8-hydroxywarfarin was observed when HPC were exposed to beta-naphthoflavone. Unique conjugation patterns were found when hydroxylated warfarins were substituted for warfarin in HPC medium. Both 7- and 8-hydroxywarfarin were converted to one sulfate and two glucuronide conjugates, whereas 4'-hydroxywarfarin was converted to a single glucuronide conjugate. A spectral library of these conjugates was used to identify the major conjugates of warfarin formed by rat HPC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732719

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  In silico pharmacogenetics of warfarin metabolism.

Authors:  Yingying Guo; Paul Weller; Erin Farrell; Paul Cheung; Bill Fitch; Douglas Clark; Shao-yong Wu; Jianmei Wang; Guochun Liao; Zhaomei Zhang; John Allard; Janet Cheng; Anh Nguyen; Sharon Jiang; Steve Shafer; Jonathan Usuka; Mohammad Masjedizadeh; Gary Peltz
Journal:  Nat Biotechnol       Date:  2006-05       Impact factor: 54.908

3.  Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites.

Authors:  C Preston Pugh; Dakota L Pouncey; Jessica H Hartman; Robert Nshimiyimana; Linda P Desrochers; Thomas E Goodwin; Gunnar Boysen; Grover P Miller
Journal:  Arch Biochem Biophys       Date:  2014-10-19       Impact factor: 4.013

4.  Pharmacokinetic Modeling of Warfarin ІI - Model-based Analysis of Warfarin Metabolites following Warfarin Administered either Alone or Together with Fluconazole or Rifampin.

Authors:  Shen Cheng; Darcy R Flora; Allan E Rettie; Richard C Brundage; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2022-07-07       Impact factor: 3.579

5.  Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.

Authors:  Grover P Miller; Drew R Jones; Shane Z Sullivan; Anna Mazur; Suzanne N Owen; Neil C Mitchell; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Chem Res Toxicol       Date:  2009-07       Impact factor: 3.739

6.  Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases.

Authors:  Agnieszka Zielinska; Cheryl F Lichti; Stacie Bratton; Neil C Mitchell; Anna Gallus-Zawada; Vi-Huyen Le; Moshe Finel; Grover P Miller; Anna Radominska-Pandya; Jeffery H Moran
Journal:  J Pharmacol Exp Ther       Date:  2007-10-05       Impact factor: 4.030

7.  Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin.

Authors:  Grover P Miller; Cheryl F Lichti; Agnieszka K Zielinska; Anna Mazur; Stacie M Bratton; Anna Gallus-Zawada; Moshe Finel; Jeffery H Moran; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2008-08-25       Impact factor: 3.922

8.  Metabolic profiling of HepG2 cells incubated with S(-) and R(+) enantiomers of anti-coagulating drug warfarin.

Authors:  Jing Bai; Ming Xuan Wang; Balram Chowbay; Chi Bun Ching; Wei Ning Chen
Journal:  Metabolomics       Date:  2010-11-25       Impact factor: 4.290

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.